Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Rectogesic launched in U.K.

June 1, 2005

Tentative approval for Biovail's Zolpidem ODT

June 1, 2005

New treatment option for anxiety and depression claimed by Roche

May 31, 2005

Ablynx and NRC to develop Nanobodies for CNS diseases

May 31, 2005

NDA submitted for indiplon tablets

May 31, 2005

Recent patents report new treatments for psychotic disorders

May 30, 2005

Focalin XR approved for ADHD

May 30, 2005

Synthetic derivative of rocaglaol effective in preclinical models of neurodegenerative diseases

May 30, 2005

Recent patents disclose novel analgesic agents

May 27, 2005

VistaGen Therapeutics receives NIH grant for preclinical studies of AV-101 for epilepsy

May 27, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...